Clinical Trial Update: Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial CALHYS evaluating ribociclib in combination with hormone therapy and hypofractionated radiotherapy for elderly patients with HER2-negative bre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Kisqali (ribociclib) (ribociclib)

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: HER2 Negative Breast Cancer Not Immediately Operated | Phase 1, Phase 2 | Status: WITHDRAWN